MHRA finds evidence does not support a link between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and suicidal and self-injurious thoughts and actions Following a thorough review, the Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the available evidence does not establish a causal relationship between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and suicidal behaviour, suicidal ideation, self-injury and depression
doi:10.3390/nu15153492 Alorfi NM, Alshehri FS
Your bodys naturally occurring GLP-1 hormone helps to reduce hunger and support healthy blood sugar
Functional medicine practitioners will work to ensure an early diagnosis of your thyroid condition, and will then optimize thyroid medications (to achieve optimal versus normal TSH levels)
Chronic benfotiamine administration was also shown to decrease the number of neurofibrillary tangles in certain brain regions and improve survival in a mouse model (63)
If simple measures do not provide relief within two to three weeks, further medical review is appropriate to exclude other causes and consider alternative supplementation routes
